135 Pill - yellow capsule/oblong, 20mm
Pill with imprint 135 is Yellow, Capsule/Oblong and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Nimodipine is used in the treatment of Subarachnoid Hemorrhage and belongs to the drug class calcium channel blockers. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 135
Nimodipine
- Imprint
- 135
- Strength
- 30 mg
- Color
- Yellow
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC)
- 57664-0135 (Discontinued)
- Inactive Ingredients
-
glycerin,
peppermint oil,
water,
polyethylene glycol,
gelatin,
D&C Yellow No. 10,
titanium dioxide,
ammonia,
ferrosoferric oxide,
butyl alcohol,
isopropyl alcohol,
shellac,
alcohol,
propylene glycol,
medium-chain triglycerides
Note: Inactive ingredients may vary.
Related images for "135"
More about nimodipine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blockers
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
